Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

Yamanaka, Koji, Chun, Seung Joo, Boillee, Severine, Fujimori-Tonou, Noriko, Yamashita, Hirofumi, Gutmann, David H, Takahashi, Ryosuke, Misawa, Hidemi +1 more·2008·Nature Neuroscience
DOI 10.1038/nn2047

Cited by (1,000)

Items 401–500 of 1,000

  1. Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study
    Safa Al‐Sarraj, Andrew King, M. S. Cleveland, Pierre‐François Pradat, Andrea M. Corse, Jeffrey D. Rothstein, Peter Leigh, Bams Abila, Stewart Bates, Jens Würthner et al. · 2014 · Acta Neuropathologica Communications
  2. Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders
    Liddelow, Shane A., Olsen, Michelle L., Sofroniew, Michael V. · 2024 · Cold Spring Harbor Perspectives in Biology
  3. Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis
    Chong Gao, Qinghua Shi, Xue Pan, Jiajia Chen, Yuhong Zhang, Jiali Lang, Shan Wen, Xiaodong Liu, Tian‐Lin Cheng, Kai Lei · 2024 · Cell Reports
  4. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis
    Kazunori Tanaka, Takuya Kanno, Yoshiko Yanagisawa, Kaori Yasutake, Shinji Hadano, Fumihito Yoshii, Joh‐E Ikeda · 2011 · Experimental Neurology
  5. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies
    Shingo Kariya, Diane Bérangère Ré, Arnaud Jacquier, Katelyn N. Nelson, Serge Przedborski, Umrao R. Monani · 2012 · Human Molecular Genetics
  6. Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation
    Manoj K. Jaiswal · 2014 · Molecular and Cellular Therapies
  7. ¿Por qué degeneran las motoneuronas? Actualización en la patogenia de la esclerosis lateral amiotrófica
    Javier Riancho, I. Gonzalo, María Ruiz‐Soto, José Berciano · 2016 · Neurología
  8. Glia-specific autophagy dysfunction in ALS
    Laura Strohm, Christian Behrends · 2019 · Seminars in Cell and Developmental Biology
  9. Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
    Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi, Soomin C. Song, Yaron Bram, Constance Q. Zhou, Stephanie Jackvony, Robert E. Schwartz, Robert C. Froemke, Adam L. Orr et al. · 2023 · Science Advances
  10. Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments
    Luc Dupuis, Andoni Echaniz‐Laguna · 2010 · Current Drug Targets
  11. Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
    Jason R. Thonhoff, Luis D. Ojeda, Ping Wu · 2009 · Current Stem Cell Research & Therapy
  12. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
    Linghua Qiu, Tao Qiao, Melissa A. Beers, Weijia Tan, Hongyan Wang, Bin Yang, Zuoshang Xu · 2013 · Molecular Neurodegeneration
  13. A MicroRNA124 Target Sequence Restores Astrocyte Specificity of gfaABC1D-Driven Transgene Expression in AAV-Mediated Gene Transfer
    Grit Taschenberger, Julia Tereshchenko, Sebastian Kügler · 2017 · Molecular Therapy — Nucleic Acids
  14. Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders
    Taejoon Kim, Bokyeong Song, Im‐Soon Lee · 2020 · International Journal of Molecular Sciences
  15. Evidence for an early innate immune response in the motor cortex of ALS
    Javier H. Jara, Barış Genç, Macdonell J. Stanford, Peter Pytel, Raymond P. Roos, Sandra Weıntraub, Marsel M. Mesulam, Eileen H. Bigio, Richard J. Miller, P. Hande Özdi̇nler · 2017 · Journal of Neuroinflammation
  16. Motor neuron–immune interactions: the vicious circle of ALS
    Ana G. Barbeito, Pinar Mesci, Séverine Boillée · 2010 · Journal of Neural Transmission
  17. Influence of Methylene Blue on Microglia-Induced Inflammation and Motor Neuron Degeneration in the SOD1G93A Model for ALS
    Payam Dibaj, Jana Zschüntzsch, Heinz Steffens, Jörg Scheffel, Bettina Göricke, Jochen Hans Weishaupt, Karim Le Meur, Frank Kirchhoff, Uwe‐Karsten Hanisch, Eike Dieter Schomburg et al. · 2012 · PLoS ONE
  18. Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis
    Mary McCrate, Brian K. Kaspar · 2008 · NeuroMolecular Medicine
  19. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis
    Laura Pasetto, Silvia Pozzi, Mariachiara Castelnovo, Manuela Basso, Álvaro G. Estévez, Stefano Fumagalli, Maria Grazia De Simoni, Valeria Castellaneta, Paolo Bigini, Elena Restelli et al. · 2016 · Journal of Neuroscience
  20. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
    Ana G. Barbeito, Laura Martínez Palma, Marcelo R. Vargas, Mariana Pehar, Nelly Mañáy, Joseph S. Beckman, Luis Barbeito, Patricia Cassina · 2009 · Neurobiology of Disease
  21. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)
    Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch · 2014 · Experimental Neurology
  22. Advances in stem cell research for Amyotrophic Lateral Sclerosis
    Sophia T. Papadeas, Nicholas John Maragakis · 2009 · Current Opinion in Biotechnology
  23. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage‐of‐disease specific manner
    Joo Hyun Kim, Abigail Lukowicz, Wenhui Qu, Andrea Johnson, Marija Cvetanović · 2018 · Glia
  24. In Vitro Modeling of Nerve–Muscle Connectivity in a Compartmentalized Tissue Culture Device
    Carolina Barcellos Machado, Perrine Pluchon, Peter Harley, Mark Rigby, Victoria Gonzalez Sabater, Danielle C. Stevenson, Stephanie Hynes, Andrew Lowe, Juan Burrone, Virgile Viasnoff et al. · 2019 · Advanced Biosystems
  25. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice
    Elisabetta Bonfanti, Tiziana Bonifacino, Stefano Raffaele, Marco Milanese, Morgante Erica, Giambattista Bonanno, Maria P. Abbracchio, Marta Fumagalli · 2020 · International Journal of Molecular Sciences
  26. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
    Vartika R. Mishra, Diane Bérangère Ré, Virginia Le Verche, Mariano J. Alvarez, Alessandro Vasciaveo, Arnaud Jacquier, Paschalis-Tomas Doulias, Todd M. Greco, Monica Nizzardo, Dimitra A. Papadimitriou et al. · 2020 · Nature Communications
  27. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis
    Luyang Xiong, Michael G. McCoy, Hitoshi Komuro, Xiaoxia Z. West, Valentin P. Yakubenko, Detao Gao, Tejasvi Dudiki, Amanda Milo, Jacqueline M. Chen, Eugene A. Podrez et al. · 2021 · Free Radical Biology and Medicine
  28. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase
    Gowing, Genevieve, Lalancette-Hébert, Mélanie, Audet, Jean-Nicolas, Dequen, Florence, Julien, Jean-Pierre · 2009 · Experimental Neurology
  29. Human Astrocytes Exhibit Tumor Microenvironment-, Age-, and Sex-Related Transcriptomic Signatures
    Mitchell C. Krawczyk, Jillian R. Haney, Lin Pan, Christine Caneda, Rana R. Khankan, Samuel D. Reyes, Julia W. Chang, Marco Morselli, Harry V. Vinters, Anthony Wang et al. · 2022 · Journal of Neuroscience
  30. Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
    Justin You, Mohieldin Youssef, Jhune Rizsan Santos, Jooyun Lee, Jeehye Park · 2023 · Biology
  31. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
    Kim A. Staats, Ludo Van Den Bosch · 2009 · Journal of Biological Physics
  32. Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1
    Marcelo R. Vargas, Mariana Pehar, Pablo Díaz‐Amarilla, Joseph S. Beckman, Luis Barbeito · 2008 · Journal of Neuroscience Research
  33. Astrocytes in selective vulnerability to neurodegenerative disease
    Till S. Zimmer, Adam L. Orr, Anna G. Orr · 2024 · Trends in Neurosciences
  34. An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non–cell autonomous neurodegeneration
    Gilbert Gallardo, Jessica Barowski, John Ravits, Teepu Siddique, Jerry B. Lingrel, Janice Robertson, Hanno Steen, Azad Bonni · 2014 · Nature Neuroscience
  35. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis
    Burcin Ikiz, Mariano J. Alvarez, Diane Bérangère Ré, Virginia Le Verche, Kristin A. Politi, Francesco Lotti, Sudarshan Phani, Radhika Pradhan, Changhao Yu, Gist F. Croft et al. · 2015 · Cell Reports
  36. Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases
    Detlev Boison · 2011 · Current Topics in Medicinal Chemistry
  37. GLT1 overexpression in SOD1G93A mouse cervical spinal cord does not preserve diaphragm function or extend disease
    Ke Li, Tamara J. Hala, Suneil Seetharam, David J. Poulsen, Megan C. Wright, Angelo C. Lepore · 2015 · Neurobiology of Disease
  38. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Marco Milanese, Francesco Giribaldi, Marcello Melone, Tiziana Bonifacino, Ilaria Musante, Enrico Carminati, Pia Irene Anna Rossi, Laura Vergani, Adriana Voci, Fiorenzo Conti et al. · 2013 · Neurobiology of Disease
  39. Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis
    Marco Pagani, Johanna Öberg, Fabrizio De Carli, Andrea Calvo, Cristina Moglia, Antonio Canosa, Flavio Mariano Nobili, Silvia Daniela Morbelli, Piercarlo Fania, Angelina Cistaro et al. · 2015 · Human Brain Mapping
  40. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
    Jong-Min Lee, V. Tan, D. Lovejoy, N. Braidy, D. Rowe, B. Brew, G. Guillemin · 2017 · Neuropharmacology
  41. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
    Marc‐Olivier Deguise, Rashmi Kothary · 2017 · Annals of Clinical and Translational Neurology
  42. Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
    Tommaso Iannitti, Joseph M. Scarrott, Shibi B. Likhite, Ian Coldicott, Katherine E. A. Lewis, Paul Roy Heath, Adrian Higginbottom, Monika A. Myszczynska, Marta Milo, Guillaume M. Hautbergue et al. · 2018 · Molecular Therapy — Nucleic Acids
  43. Revisiting the role of the innate immune complement system in ALS
    Sandra E. Parker, Angela M. Hanton, Stephen N. Stefanou, Peter G. Noakes, Trent M. Woodruff, John D. Lee · 2019 · Neurobiology of Disease
  44. Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment
    Lu-Lin Jiang, Bing Zhu, Yingjun Zhao, Xiaoguang Li, Tong‐Fei Liu, Juan Piña-Crespo, Lisa Zhou, Wenxi Xu, Maria José Gómez-Rodríguez, Haiyang Yu et al. · 2019 · Journal of Clinical Investigation
  45. Altered astrocytic expression of TDP-43 does not influence motor neuron survival
    Amanda M. Haidet-Phillips, Sarah K. Gross, Timothy L. Williams, Alisha Tuteja, Alex Sherman, Myungsung Ko, Yun Ha Jeong, Philip C. Wong, Nicholas John Maragakis · 2013 · Experimental Neurology
  46. Crosstalk between astrocytes and motor neurons: What is the message?
    Ludo Van Den Bosch, Wim Robberecht · 2008 · Experimental Neurology
  47. Functional Multipotency of Stem Cells: A Conceptual Review of Neurotrophic Factor-Based Evidence and Its Role in Translational Research
    Dae Yul Yang, Dou Yu, Dou Dou, Ropper, Alexander E, Li, Jianxue, Serdar Kabataş, Serdar, Wakeman et al. · 2011 · Current Neuropharmacology
  48. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1
    Eiichi Tokuda, Eriko Okawa, S. Watanabe, S.-i. Ono · 2013 · Human Molecular Genetics
  49. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS
    Saravanan Karumbayaram, Theresa Kathleen Kelly, Andres A. Paucar, Anne Jessica Roe, Joy A. Umbach, Andrew C. Charles, Steven A. Goldman, Harley I. Kornblum, Martina Wiedau‐Pazos · 2009 · Disease Models & Mechanisms
  50. The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis
    Takao Fujisawa, Motoo Takahashi, Yuka Tsukamoto, Namiko Yamaguchi, Masayoshi Nakoji, Megumi Endo, Hiroshi Kodaira, Yuki Hayashi, Hideki Nishitoh, Isao Naguro et al. · 2015 · Human Molecular Genetics
  51. Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1G93A Mouse Model of ALS by Enhancing Autophagic Flux
    Xiaojie Zhang, Sheng Chen, Kaili Lu, Feng Wang, Jiangshan Deng, Zhouwei Xu, Xiuzhe Wang, Qinming Zhou, Weidong Le, Yuwu Zhao · 2019 · Aging and Disease
  52. Enhanced neuronal Met signalling levels in ALS mice delay disease onset
    Matthieu Genestine, E Caricati, Annalisa Fico, Sylvie Richelme, Hessameh Hassani, Claire Sunyach, Fabienne Lamballe, Giancarlo Panzica, Brigitte Pettmann, Françoise Helmbacher et al. · 2011 · Cell Death and Disease
  53. Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse
    Wendy W. Yang, Richard L. Sidman, Tatyana V. Taksir, Christopher M. Treleaven, Jonathan A. Fidler, Seng H. Cheng, James C. Dodge, Lamya S. Shihabuddin · 2010 · Experimental Neurology
  54. Epigenetic changes in T‐cell and monocyte signatures and production of neurotoxic cytokines in ALS patients
    Larry Lam, Lydia Chin, Ramesh Chandra Halder, Bien Sagong, Sam Famenini, James William Sayre, Dennis J. Montoya, Liudmilla Rubbi, Matteo A. Pellegrini, Milan Fiala · 2016 · The FASEB Journal
  55. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death
    Maria Antonietta Ajmone‐Cat, Angela Onori, Camilla Toselli, Eleonora Stronati, Mariangela Morlando, Irene Bozzoni, Emanuela Monni, Zaal Kokaia, Giuseppe Lupo, Luisa Minghetti et al. · 2019 · Scientific Reports
  56. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1 G37R ALS Mouse Model
    Éric Martineau, Danielle Arbour, Joanne Vallée, Richard Robitaille · 2020 · Journal of Neuroscience
  57. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS)
    Amanda M. Haidet-Phillips, Nicholas John Maragakis · 2015 · Brain Research
  58. Absence of Nrf2 or Its Selective Overexpression in Neurons and Muscle Does Not Affect Survival in ALS-Linked Mutant hSOD1 Mouse Models
    Marcelo R. Vargas, Neal C. Burton, Li Gan, Delinda A. Johnson, Matthias Schäfer, Sabine Werner, Jeffrey Allan Johnson · 2013 · PLoS ONE
  59. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis
    El Oussini, Hajer, Scekic‐Zahirovic, Jelena, Vercruysse, Pauline, Marques, Christine, Dirrig‐Grosch, Sylvie, Dieterlé, Stéphane, Picchiarelli, Gina, Sinniger, Jérôme, Rouaux, Caroline, Dupuis, Luc · 2017 · Annals of Neurology
  60. Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
    Bowerman, Melissa, Vincent, Thierry, Scamps, Frédérique, Perrin, Florence E., Camu, William, Raoul, Cédric · 2013 · Frontiers in Cellular Neuroscience
  61. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD
    Fujioka, Yusuke, Ishigaki, Shinsuke, Masuda, Akio, Iguchi, Yohei, Udagawa, Tsuyoshi, Watanabe, Hirohisa, Katsuno, Masahisa, Ohno, Kinji, Sobue, Gen · 2013 · Scientific Reports
  62. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
    Anne-Lene Kjældgaard, Katrine Pilely, Karsten Skovgaard Olsen, Stephen Wørlich Pedersen, Anne Øberg Lauritsen, Kirsten Møller, Peter Garred · 2018 · Molecular Immunology
  63. Role of astrocytes in major neurological disorders: The evidence and implications
    Caterina Scuderi, Claudia Stecca, Aniello Iacomino, Luca Steardo · 2013 · IUBMB Life
  64. Modeling cognition and disease using human glial chimeric mice
    Steven A. Goldman, Maiken Nedergaard, Martha S. Windrem · 2015 · Glia
  65. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis
    Shyuan Thieu Ngo, Frederik J. Steyn · 2015 · Cell Regeneration
  66. The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis
    Tino Prell, Janin Lautenschläger, Otto Wilhelm Witte, Maria Teresa Carrı̀, Julian Großkreutz · 2012 · European Journal of Neuroscience
  67. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
    David J. Baker, Daniel J. Blackburn, Marcus Keatinge, Dilraj Singh Sokhi, Paulius Viskaitis, Paul Roy Heath, Laura Ferraiuolo, Janine Kirby, Pamela J. Shaw · 2015 · Frontiers in Cellular Neuroscience
  68. Targeting angiogenin in therapy of amyotropic lateral sclerosis
    Hiroko Kishikawa, David Wu, Guo-fu Hu · 2008 · Expert Opinion on Therapeutic Targets
  69. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis
    Liliana Brambilla, Giulia Guidotti, Francesca Martorana, Anand M. Iyer, Eleonora Aronica, Chiara F. Valori, Daniela Rossi · 2016 · Human Molecular Genetics
  70. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
    Andrew Paul Tosolini, James N. Sleigh · 2017 · Frontiers in Molecular Neuroscience
  71. Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS
    Ella Zeldich, Ci-Di Chen, Emma Boden, Bryce Howat, Jason S. Nasse, Dean Zeldich, Anthony G. Lambert, Andrea Yuste, Jonathan D. Cherry, Rebecca Mathias et al. · 2019 · Journal of Molecular Neuroscience
  72. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis
    Toru Yamashita, Yoshihiro Kushida, Shohei Wakao, Koh Tadokoro, Emi Nomura, Yoshio Omote, Mami Takemoto, Nozomi Hishikawa, Yasuyuki Ohta, Mari Dezawa et al. · 2020 · Scientific Reports
  73. Genetic approaches to study glial cells in the rodent brain
    Frank W. Pfrieger, Michał Ślęzak · 2011 · Glia
  74. Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS
    Kenichi Hirano, Tomohiro Ohgomori, Kazuyoshi Kobayashi, Fumiaki Tanaka, Tomohiro Matsumoto, Takamitsu Natori, Yukihiro Matsuyama, Kenji Uchimura, Kazuma Sakamoto, Hideyuki Takeuchi et al. · 2013 · PLoS ONE
  75. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats
    Genevíève Gowing, Brandon Shelley, Kevin Staggenborg, Amanda Mae Hurley, Pablo Avalos, Jesse Victoroff, Jessica Latter, Leslie Garcia, Clive Niels Svendsen · 2013 · Neuroreport
  76. Prion-like mechanisms in amyotrophic lateral sclerosis
    Jacob I. Ayers, Neil R. Cashman · 2018 · Handbook of clinical neurology
  77. Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose
    Francesca Massenzio, Emiliano Peña‐Altamira, Sabrina Petralla, Marco Virgili, Giampaolo Zuccheri, Andrea Miti, Elisabetta Polazzi, Ilaria Mengoni, Deborah Piffaretti, Barbara Monti · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  78. Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit
    Shamchal Bakavayev, Nimrod Chetrit, Tatiana Zvagelsky, Rasha Emad Mansour, Maria Vyazmensky, Ze’ev Barak, Adrian Israelson, Stanislav Engel · 2019 · Scientific Reports
  79. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
    Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, Adrian Israelson · 2021 · Cells
  80. Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1G93A Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
    Mariana Pehar, Gyda C. Beeson, Craig Cano Beeson, Jeffrey Allan Johnson, Marcelo R. Vargas · 2014 · PLoS ONE
  81. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats
    Angelo C. Lepore, Christopher Tolmie, John O'Donnell, Megan C. Wright, Christine M. Dejea, Britta M. Rauck, Ahmet Höke, Anthony R. Ignagni, Raymond P. Onders, Nicholas John Maragakis · 2010 · Neurobiology of Disease
  82. Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice
    Ryo Yamasaki, Masahito Tanaka, Mami Fukunaga, Takahisa Tateishi, Hitoshi Kikuchi, Kyoko Motomura, Takuya Matsushita, Yasumasa Ohyagi, Jun‐ichi Kira · 2010 · Journal of Neuroimmunology
  83. ALS: Focus on purinergic signalling
    Cinzia Volonté, Savina Apolloni, Maria Teresa Carrı̀, Nadia D’Ambrosi · 2011 · Pharmacology & Therapeutics
  84. Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model
    Mudan Cai, Eun Jin Yang · 2016 · The American Journal of Chinese Medicine
  85. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis
    Christine V. Fontanilla, Huiying Gu, Qingpeng Liu, Timothy Z. Zhu, Changwei Zhou, Brian H. Johnstone, Keith L. March, Robert M. Pascuzzi, Martin Rhys Farlow, Yansheng Du · 2015 · Scientific Reports
  86. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
    Nadia D’Ambrosi, Mauro Cozzolino, Maria Teresa Carrı̀ · 2017 · Antioxidants and Redox Signaling
  87. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model
    Shun Mitsui, Asako Otomo, Masahisa Nozaki, Suzuka Ono, Kai Sato, Ryohei Shirakawa, Hiroaki Adachi, Masashi Aoki, Gen Sobue, Huifang Shang et al. · 2018 · Molecular Brain
  88. Mitophagy Modulation, a New Player in the Race against ALS
    Enrique Madruga, Inés Maestro, Ana Martı́nez · 2021 · International Journal of Molecular Sciences
  89. Immune-mediated processes in neurodegeneration: where do we stand?
    Fakhoury, Marc · 2016 · Journal of Neurology
  90. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
    Maria Chiara Trolese, Alessandro Mariani, Mineko Terao, Massimiliano De Paola, Paola Fabbrizio, Francesca M. Sironi, Mami Kurosaki, Silvia Bonanno, Stefania Marcuzzo, Pia Bernasconi et al. · 2020 · EBioMedicine
  91. A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells
    Ying Li, Umamahesw Balasubramanian, Devon A. Cohen, Ping-Wu Zhang, Elizabeth Mosmiller, Rita Sattler, Nicholas John Maragakis, Jeffrey D. Rothstein · 2015 · PLoS ONE
  92. Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
    Sebastian A. Lewandowski, Ingrid Nilsson, Linda Fredriksson, Peter Lönnerberg, Lars Muhl, Manuel Zeitelhofer, Milena Z. Adzemovic, Susanne Nichterwitz, Daniel A. Lawrence, Eva Hedlund et al. · 2015 · Acta Neuropathologica
  93. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
    Stefanie Rauskolb, Benjamin Dombert, Michael Sendtner · 2016 · Neurobiology of Disease
  94. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability
    Pablo Rozas, Leslie Bargsted, Francisca Martínez, Claudio A. Hetz, Danilo B. Medinas · 2016 · Neuroscience Letters
  95. Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
    Disi An, Ryosuke Fujiki, Dylan E. Iannitelli, John W. Smerdon, Shuvadeep Maity, Matthew F. Rose, Alon Gelber, Elizabeth K. Wanaselja, Ilona Yagudayeva, Joun Y. Lee et al. · 2019 · eLife
  96. Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
    Giulia Guidotti, Chiara Scarlata, Liliana Brambilla, Daniela Rossi · 2021 · Cells
  97. Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS
    Francesca Provenzano, Sophie Nyberg, Debora Giunti, Carola Torazza, Benedetta Parodi, Tiziana Bonifacino, Cesare Usai, Nicole Kerlero de Rosbo, Marco Milanese, Antonio Uccelli et al. · 2022 · Cells
  98. Cerebral sterile inflammation in neurodegenerative diseases
    Otani, Kento, Shichita, Takashi · 2020 · Inflammation and Regeneration
  99. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
    Elizabeth E. Evans, Vikas A. Mishra, Crystal L. Mallow, Elaine M. Gersz, Leslie Balch, Alan P. Howell, Christine A. Reilly, Ernest Smith, Terrence Lee Fisher, Maurice Zauderer · 2022 · Journal of Neuroinflammation
  100. Elevated levels of IFNγ and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis
    Julianne Aebischer, Anice Moumen, Véronique Sazdovitch, Danielle Seilhean, Vincent Meininger, Cédric Raoul · 2012 · European Journal of Neurology